Just because you will not see the work completed does not mean you are free not to take it up.
Many professionals in industry are gung-ho at the start of a project but lose interest as it progresses, so ensure the leaders of projects have staying-power.
Good judgment comes from experience, and experience comes from bad judgment.
Do not seek strategic clinical advice from academicians who believe they can become investigators on the trials they propose or endorse, because they have a serious conflict of interest.
The Executive Summary in a briefing package or other data/information sent to a regulatory agency must capture all of your key messages.
SPILKERISMS
.jpg){kind=small}
Spilkerisms presents weekly postings of pithy comments and pearls from myself and others that will help people remember the principles, tips and lessons of developing, discovering, marketing, regulatorily approving and related topics for new pharmaceutical and medical products, including drugs, medical devices, biotechnology products, diagnostics, vaccines and others. These pearls will help avoid errors and increase one's chances of success. Reader feedback is welcomed. Readers wishing more information may visit my website (www.bertspilker.com) or email me at bspilker@comcast.net. My latest book "Guide to Drug Development: A Comprehensive Review and Assessment" is available from Lippincott, Williams and Wilkins in Philadelphia (pub. 2009).
.jpg)